Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ingevity (NGVT) EBT (2016 - 2025)

Ingevity (NGVT) has disclosed EBT for 11 consecutive years, with -$105.4 million as the latest value for Q4 2025.

  • Quarterly EBT fell 537.34% to -$105.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$159.1 million through Dec 2025, up 51.55% year-over-year, with the annual reading at -$142.1 million for FY2025, 1.14% down from the prior year.
  • EBT for Q4 2025 was -$105.4 million at Ingevity, down from $62.2 million in the prior quarter.
  • The five-year high for EBT was $95.8 million in Q3 2022, with the low at -$334.6 million in Q2 2024.
  • Average EBT over 5 years is $3.7 million, with a median of $34.2 million recorded in 2021.
  • The sharpest move saw EBT surged 1164.44% in 2022, then tumbled 801.47% in 2024.
  • Over 5 years, EBT stood at $36.3 million in 2021, then tumbled by 45.73% to $19.7 million in 2022, then crashed by 170.56% to -$13.9 million in 2023, then surged by 273.38% to $24.1 million in 2024, then crashed by 537.34% to -$105.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$105.4 million, $62.2 million, and -$142.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.